title: Serum lipid abnormalities in a chemical/viral mouse model for Reye's syndrome.
abstract: Neonatal mice given nontoxic dermal applications of an industrial surfactant, Toximul MP8 (Tox), and subsequently infected with sublethal doses of mouse-adapted human Influenza B (Lee) virus (FluB) develop many of the biochemical features of Reye's Syndrome (RS). To determine whether these also include abnormal circulating lipid, we examined serum lipid profiles in the mouse model throughout the treatment course using Iatroscan-TH10. Following 10 days of exposure to surfactant, serum phospholipid and cholesterol levels were significantly reduced relative to control animals. These reductions were transient; however, four days following virus administration, significant differences in serum lipid were again evident. These abnormalities coincided and correlated with increased animal mortality. Animals that received combined Tox + virus treatment had significant decreases in serum total lipids relative to control animals, a reflection of a reduction in all lipid classes, including phospholipid, cholesterol, neutral glycerides (triglycerides plus diglycerides) and free fatty acids. Phospholipid (specifically phosphatidylcholine and lysophosphatidylcholine) and free fatty acid levels in the Tox + virus group were also significantly lower than those in animals that received virus alone. This study has demonstrated that suckling mice given chemical/viral treatment have the serum hypopanlipidemia but not the freefattyacidemia that are characteristic of RS.
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D004655:Emulsions; D009981:Influenza B virus; D008055:Lipids / Q000097:blood*; D051379:Mice; D009930:Organic Chemicals; D009976:Orthomyxoviridae Infections / Q000097:blood*; D010743:Phospholipids / Q000097:blood; D012202:Reye Syndrome / Q000097:blood*; D013501:Surface-Active Agents
chemical_list: D004655:Emulsions; D008055:Lipids; D009930:Organic Chemicals; D010743:Phospholipids; D013501:Surface-Active Agents; C019116:Toximul MP8; D002784:Cholesterol